Method for detecting anti-liver cancer efficacy of tyroserleutide, kit and gene chip used thereby
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- SHENZHEN KANGZHE PHARM CO LTD
- Publication Date
- 2006-09-27
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention relates to a method and a preparation for detecting the anticancer effect of drugs, in particular to a method for detecting the anticancer effect of tyroserleutide at the molecular level, a kit and a gene chip used therefor. Background technique
[0002] Primary liver cancer is one of the most common malignant tumors of the digestive tract in humans. Its incidence rate ranks eighth among major cancers in the world, and its mortality rate is high. It is second only to gastric cancer and esophageal cancer in the mortality rate of malignant tumors and ranks third. . China is a country with a high incidence of primary liver cancer. Its morbidity and mortality rates rank first in the world, and its mortality rate ranks second among various cancers. About 110,000 people die from liver cancer every year, accounting for about 100,000 deaths from liver cancer in the world. about 45%. Currently, surgery, radiotherapy and chemotherapy are the main...